Tilray Brands has been a bad buy in recent years, and that could remain the case for the foreseeable future.
The industry has been taking a beating in recent years, but now could be an attractive time to buy pot stocks again.
It would be quite a contrarian move to load up on the company's shares these days.
MedMen Enterprises Inc., (“MedMen" or the "Company") (CSE: MMEN) (OTCQB: MMNFF) announces it has changed its auditor from MNP LLP to Marcum LLP effective March 17, 2023.
They might not soar anytime soon, but their long-term pictures are favorable.
Tilray's shares have been hurt by lagging sales.
MedMen Enterprises Inc. (“ MedMen '' or the “ Company ”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis retailer with operations across the United States, today released the results of a new national...
The multi-state operator that Tilray looked to potentially acquire one day isn't doing all that well.
MedMen Enterprises Inc. (“ MedMen ” or the “ Company ”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis retailer with operations across the United States, continues to make progress in its restructuring...
Stranger things have happened, and the stars appear to be aligning.